RS50780B - Farmaceutske kompozicije na bazi nk2 antagonista za pedijatrijsku primenu - Google Patents

Farmaceutske kompozicije na bazi nk2 antagonista za pedijatrijsku primenu

Info

Publication number
RS50780B
RS50780B RSP-2009/0169A RSP20090169A RS50780B RS 50780 B RS50780 B RS 50780B RS P20090169 A RSP20090169 A RS P20090169A RS 50780 B RS50780 B RS 50780B
Authority
RS
Serbia
Prior art keywords
cyclo
dap
trp
phe
leu
Prior art date
Application number
RSP-2009/0169A
Other languages
English (en)
Inventor
Maria Altamura
Carlo Alberto Maggi
Alberto Aleotti
Original Assignee
Laboratori Guidotti S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratori Guidotti S.P.A. filed Critical Laboratori Guidotti S.P.A.
Publication of RS50780B publication Critical patent/RS50780B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Primena antagonista tahikinina naznačena time što je za pripremu farmaceutskih formulacija za pedijatrijsku primenu za lečenje infatilnih kolika, pri čemu su navedene formulacije u pogodnom obliku za oralnu primenu, i gde je antagonist tahikinina NK2 antagonist izabran od:ciklo((Asn(β-D-2-deoksi-2-acetamido-Glc)-Asp-Trp-Phe-Dap-Leu)ciklo(2β-5β)), (nepadutant),ciklo(( Asn((β-D-galaktopiranozil)-Asp-Trp-Phe-Dap-Leu)ciklo(2β-5β)), ciklо((Asn(4-O-(α-D-G1c)-b-D-G1c)-Asp-Trp-Phe-Dap-Leu)ciklo(2β-5β)), ciklo((Dap(laktobionil)-Asp-Trp-Phe-Dap-Leu)ciklo(2β-5β)).Prijava sadrži još 10 patentnih zahteva.
RSP-2009/0169A 2004-10-27 2005-10-26 Farmaceutske kompozicije na bazi nk2 antagonista za pedijatrijsku primenu RS50780B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000221A ITFI20040221A1 (it) 2004-10-27 2004-10-27 Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico
PCT/EP2005/055575 WO2006045820A1 (en) 2004-10-27 2005-10-26 Pharmaceutical compositions based on nk2 antagonists for pediatric use

Publications (1)

Publication Number Publication Date
RS50780B true RS50780B (sr) 2010-08-31

Family

ID=35613882

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2009/0169A RS50780B (sr) 2004-10-27 2005-10-26 Farmaceutske kompozicije na bazi nk2 antagonista za pedijatrijsku primenu

Country Status (26)

Country Link
US (2) US7727955B2 (sr)
EP (1) EP1809267B1 (sr)
JP (1) JP2008517977A (sr)
CN (1) CN101052386A (sr)
AR (1) AR051595A1 (sr)
AT (1) ATE422881T1 (sr)
AU (1) AU2005298629B2 (sr)
CA (1) CA2584481C (sr)
CY (1) CY1109803T1 (sr)
DE (1) DE602005012857D1 (sr)
DK (1) DK1809267T3 (sr)
EA (1) EA012264B1 (sr)
ES (1) ES2325413T3 (sr)
HK (1) HK1109335A1 (sr)
HR (1) HRP20090225T1 (sr)
IT (1) ITFI20040221A1 (sr)
MX (1) MX2007004461A (sr)
NO (1) NO338586B1 (sr)
NZ (1) NZ555380A (sr)
PL (1) PL1809267T3 (sr)
PT (1) PT1809267E (sr)
RS (1) RS50780B (sr)
SI (1) SI1809267T1 (sr)
UA (1) UA91988C2 (sr)
WO (1) WO2006045820A1 (sr)
ZA (1) ZA200703909B (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0614970D0 (en) * 2006-07-27 2006-09-06 R & D Sosei Ltd Compounds For Use In Therapy
IT1394304B1 (it) * 2009-05-21 2012-06-06 Malesci Sas Processo per la preparazione di ibodutant (men15596) e relativi intermedi
ITRM20120331A1 (it) * 2012-07-12 2014-01-13 Guidotti & C Spa Labor Composizioni pediatriche orali liquide contenenti nepadutant.
US20160051596A1 (en) * 2014-08-21 2016-02-25 Food Industry Research And Development Institute Novel acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
US9867857B2 (en) 2014-08-21 2018-01-16 Food Industry Research And Development Institute Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0219318A (ja) * 1988-06-30 1990-01-23 Carl R Thornfeldt 疝痛及び生歯に対する治療
IT1277835B1 (it) * 1995-03-13 1997-11-12 Menarini Farma Ind Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
IT1307809B1 (it) * 1999-10-21 2001-11-19 Menarini Ricerche Spa Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono.
MY130373A (en) * 2001-10-29 2007-06-29 Malesci Sas Linear basic compounds having nk-2 antagonist activity and formulations thereof
GB0224788D0 (en) 2002-10-24 2002-12-04 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
EA012264B1 (ru) 2009-08-28
EP1809267A1 (en) 2007-07-25
PT1809267E (pt) 2009-05-28
NZ555380A (en) 2008-12-24
AR051595A1 (es) 2007-01-24
PL1809267T3 (pl) 2009-07-31
NO20072720L (no) 2007-07-09
CA2584481C (en) 2014-07-15
NO338586B1 (no) 2016-09-12
SI1809267T1 (sl) 2009-06-30
CN101052386A (zh) 2007-10-10
ZA200703909B (en) 2008-09-25
AU2005298629A1 (en) 2006-05-04
JP2008517977A (ja) 2008-05-29
CY1109803T1 (el) 2014-09-10
MX2007004461A (es) 2007-07-11
EA200700949A1 (ru) 2007-10-26
DK1809267T3 (da) 2009-05-18
HRP20090225T1 (en) 2009-05-31
CA2584481A1 (en) 2006-05-04
ITFI20040221A1 (it) 2005-01-27
WO2006045820A1 (en) 2006-05-04
US20080090795A1 (en) 2008-04-17
EP1809267B1 (en) 2009-02-18
AU2005298629B2 (en) 2011-02-17
DE602005012857D1 (de) 2009-04-02
US7727955B2 (en) 2010-06-01
ATE422881T1 (de) 2009-03-15
US20100234284A1 (en) 2010-09-16
ES2325413T3 (es) 2009-09-03
UA91988C2 (ru) 2010-09-27
HK1109335A1 (en) 2008-06-06

Similar Documents

Publication Publication Date Title
BRPI0509074A (pt) composições farmacêuticas compreendendo agonistas do receptor da tiróide
UA83659C2 (ru) Антагонисты рецепторов p2x7 и их применение, фармацевтическая композиция на их основе, способ их получения (варианты)
MY130803A (en) New quinuclidine amide derivatives
UA86621C2 (ru) Антагонисты рецептора глюкагона, их получение и терапевтическое применение
MY144897A (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
BR0314356A (pt) Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas
MY137535A (en) New pyrrolidinium derivatives
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
SI1957484T1 (sl) Antagonisti glukagonskega receptorja, priprava in terapevtske uporabe
IS8503A (is) Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar
NO20063393L (no) Farmasoytiske preparater
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
HK1120442A1 (en) Novel opioid antagonists
IL168836A (en) Pyrimidine-sulfamides and their use as endothelin receptor antagonist
AR026916A1 (es) Combinaciones farmaceuticas y su uso en el tratamiento de desordenes gastrointestinales
UA96277C2 (en) Benzimidazole derivatives
GEP20115322B (en) Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
HRP20090225T1 (en) Pharmaceutical compositions based on nk2 antagonists for pediatric use
BR0311898A (pt) Tratamento de associação para depressão e ansiedade com antagonistas de nk1 e nk3
ATE383345T1 (de) Quinoxalin-3-on-verdindungen als orexin-rezeptor antagonisten.
AU1092800A (en) N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists
BR0213574A (pt) Compostos básicos lineares apresentando atividade antagonista do nk-2 e formulações contendo os mesmos
EA200500671A1 (ru) Фармацевтический состав оланзапина
HUP0202847A2 (hu) Inszekticid és akaricid hatású szinergetikus hatóanyag-kombinációk, előállításuk és alkalmazásuk
DE60301261D1 (de) Pharmazeutische zusammensetzungen enthaltend 17alpha-furanylester von 17beta-carbothioat androstanderivaten und einen muskarinrezeptorantagonist